News

December 2019: We are excited to announce that we are in the process of licensing and commercializing a multivalent subunit EHDV vaccine. Click here for more information.

February 2021: BioStone Animal health was awarded a grant from The National Pork Board for Classical Swine Fever (CSF) antibodies DIVA ELISA development. Click here for more information.